Clinical Trials Logo

Male Contraception clinical trials

View clinical trials related to Male Contraception.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03452111 Active, not recruiting - Healthy Clinical Trials

Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception

Start date: October 25, 2018
Phase: Phase 2
Study type: Interventional

The long term objective is to develop a gel to be used as a male contraceptive.

NCT ID: NCT03298373 Active, not recruiting - Healthy Men Clinical Trials

28-Day Repeat-Dose, Dose Escalation Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

CCN014A
Start date: November 9, 2017
Phase: Phase 1
Study type: Interventional

This is a Phase I multicenter, double-blind, repeat dose, dose-escalating study, in healthy men to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC).

NCT ID: NCT02754687 Active, not recruiting - Healthy Men Clinical Trials

Single Dose, Dose-Ranging Study of 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) in Healthy Men

CCN014
Start date: April 2016
Phase: Phase 1
Study type: Interventional

The long term objective is to develop a new male hormone 11-β Methyl Nortestosterone Dodecylcarbonate (11β-MNTDC) as a male hormonal contraceptive.